Grimes & Company »

Akebia Therapeutics shares owned by Grimes & Company

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Grimes & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $18k 10k 1.83

More positions owned by Grimes & Company

Ishares Tr Core Msci Eafe (IEFA)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Spdr Ser Tr Bloomberg Sht Te (SJNK)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Ishares Tr Core S&p500 Etf (IVV)
John Hancock Exchange Traded Mltfctr Lrg Cap (JHML)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr Nuveen Bloomberg (HYMB)
Vaneck Etf Trust High Yld Munietf (HYD)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Grimes & Company

Top funds holding Akebia Therapeutics

Satter Management
Vanguard Group
Millennium Management
Jacobs Levy Equity Management
Federated Investors
Assenagon Asset Management
Connor, Clark & Lunn Investment Management
Citadel Advisors
Citigroup
Bank of America Corporation
Sapient Capital
Two Sigma Investments
Russell Investments
Two Sigma Advisers
UBS Group

View all funds holding Akebia Therapeutics